J Korean Thyroid Assoc.  2015 May;8(1):75-80. 10.11106/cet.2015.8.1.75.

Association between Serum Gamma-Glutamyl Transferase and Thyroid Cancer in an Ultrasonographically Screened Population

• Han JM
• Kim TY
• Kim WG
• Song DE
• Hong SJ
• Bae SJ
• Kim HK
• Shong YK
• Kim WB

• KMID: 2149623
• DOI: http://doi.org/10.11106/cet.2015.8.1.75

Abstract

BACKGROUND AND OBJECTIVES
We reported recently a positive correlation between obesity and thyroid cancer in women. Serum gamma-glutamyl transferase (GGT) is regarded as a marker of exposure to environmental pollutants, cancer-causing xenobiotic. This study was conducted to evaluate the mechanism behind the association of obesity with thyroid cancer. We hypothesized serum GGT may be a surrogate for persistent organic pollutants to explain the connection between obesity and thyroid cancer.
MATERIALS AND METHODS
We obtained data from 15,131 subjects who underwent a routine health checkup including thyroid ultrasonography from 2007 to 2008 at the Health Screening and Promotion Center of Asan Medical Center. Suspicious nodules were examined by ultrasonography-guided aspiration. Those with a history of hepatobiliary disease and abnormal result of liver function test were excluded. Serum GGT cut-off points were the 25th, 50th, and 75th sex-specific percentiles.
RESULTS
A total of 15,131 subjects (7662 men and 7469 women) were screened by thyroid ultrasonography. Thyroid cancers were diagnosed in 260 patients. After adjustment of age, smoking status, alcohol intake, body mass index, compared with the lowest serum GGT quartile, odds ratios (95% confidence intervals) of risk of thyroid cancer were 0.54 (0.28-0.99) for 2nd quartile, 0.92 (0.56-1.50) for 3rd quartile, and 0.61 (0.34-1.09) for 4th quartile in men. In women, the adjusted odds ratios were 1.06 (0.66-1.72), 1.18 (0.77-1.85), and 0.63 (0.38-1.06) for the 2nd, 3rd, and 4th quartile, respectively.
CONCLUSION
Elevated GGT is not associated with a higher prevalence of thyroid cancer in either gender when evaluated in a routine health checkup setting.

Keyword

Gamma-glutamyl transferase; Persistent organic pollutant; Thyroid cancer; Obesity

MeSH Terms

Body Mass Index
Chungcheongnam-do
Environmental Pollutants
Female
Humans
Liver Function Tests
Male
Mass Screening
Obesity
Odds Ratio
Prevalence
Smoke
Smoking
Thyroid Gland
Thyroid Neoplasms*
Transferases*
Ultrasonography
Environmental Pollutants
Smoke
Transferases

Figure

• 

  Fig. 1. The prevalence of thyroid cancer according to GGT quartiles. These prevalence estimates are not adjusted for other factors. Quartiles for GGT: 4.0-16.9, 17.0-24.9, 25.0-39.9, and 40.0-614.0 U/L in men; 4.0-9.9, 10.0-11.9, 12.0-16.9,and 17.0-309.0 U/L in women. GGT: gamma-glutamyl transferase.

Reference

References

1. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA. 2006; 295(18):2164–7.

2. Chen AY, Jemal A, Ward EM. Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer. 2009; 115(16):3801–7.

3. Blomberg M, Feldt-Rasmussen U, Andersen KK, Kjaer SK. Thyroid cancer in Denmark 1943-2008, before and after iodine supplementation. Int J Cancer. 2012; 131(10):2360–6.

4. Imaizumi M, Usa T, Tominaga T, Neriishi K, Akahoshi M, Nakashima E. et al. Radiation dose-response relationships for thyroid nodules and autoimmune thyroid diseases in Hiroshima and Nagasaki atomic bomb survivors 55-58 years after radiation exposure. JAMA. 2006; 295(9):1011–22.

5. Preston-Martin S, Franceschi S, Ron E, Negri E. Thyroid cancer pooled analysis from 14 case-control studies: what have we learned? Cancer Causes Control. 2003; 14(8):787–9.

6. Iribarren C, Haselkorn T, Tekawa IS, Friedman GD. Cohort study of thyroid cancer in a San Francisco Bay area population. Int J Cancer. 2001; 93(5):745–50.

7. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008; 371(9612):569–78.

8. Han JM, Kim TY, Jeon MJ, Yim JH, Kim WG, Song DE. et al. Obesity is a risk factor for thyroid cancer in a large, ultrasonographically screened population. Eur J Endocrinol. 2013; 168(6):879–86.

9. Lee DH, Jacobs DR Jr. Association between serum concentrations of persistent organic pollutants and gamma glutamyltransferase: results from the National Health and Examination Survey 1999-2002. Clin Chem. 2006; 52(9):1825–7.

10. Goldberg DM, Martin JV. Role of gamma-glutamyl transpeptidase activity in the diagnosis of hepatobiliary disease. Digestion. 1975; 12(4-6):232–46.

11. Teschke R, Brand A, Strohmeyer G. Induction of hepatic microsomal gamma-glutamyltransferase activity following chronic alcohol consumption. Biochem Biophys Res Commun. 1977; 75(3):718–24.

12. Strasak AM, Rapp K, Brant LJ, Hilbe W, Gregory M, Oberaigner W. et al. Association of gamma-glutamyltransferase and risk of cancer incidence in men: a prospective study. Cancer Res. 2008; 68(10):3970–7.

13. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004; 363(9403):157–63.

14. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ. et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2006; 16(2):109–42.

15. Renehan AG, Roberts DL, Dive C. Obesity and cancer: pathophysiological and biological mechanisms. Arch Physiol Biochem. 2008; 114(1):71–83.

16. Wolin KY, Carson K, Colditz GA. Obesity and cancer. Oncologist. 2010; 15(6):556–65.

17. Pisani P. Hyper-insulinaemia and cancer, meta-analyses of epidemiological studies. Arch Physiol Biochem. 2008; 114(1):63–70.

18. Jousilahti P, Rastenyte D, Tuomilehto J. Serum gamma-glutamyl transferase, self-reported alcohol drinking, and the risk of stroke. Stroke. 2000; 31(8):1851–5.

19. Lim JS, Lee DH, Park JY, Jin SH, Jacobs DR Jr. A strong interaction between serum gamma-glutamyltransferase and obesity on the risk of prevalent type 2 diabetes: results from the Third National Health and Nutrition Examination Survey. Clin Chem. 2007; 53(6):1092–8.

20. Ruttmann E, Brant LJ, Concin H, Diem G, Rapp K, Ulmer H. et al. Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults. Circulation. 2005; 112(14):2130–7.

21. Ryu S, Chang Y, Kim DI, Kim WS, Suh BS. Gamma-glutamyltransferase as a predictor of chronic kidney disease in nonhypertensive and nondiabetic Korean men. Clin Chem. 2007; 53(1):71–7.

22. Lee DH, Silventoinen K, Jacobs DR Jr, Jousilahti P, Tuomileto J. Gamma-glutamyltransferase, obesity, and the risk of type 2 diabetes: observational cohort study among 20,158 middle-aged men and women. J Clin Endocrinol Metab. 2004; 89(11):5410–4.

23. Franzini M, Corti A, Lorenzini E, Paolicchi A, Pompella A, De Cesare M. et al. Modulation of cell growth and cisplatin sensitivity by membrane gamma-glutamyltransferase in melanoma cells. Eur J Cancer. 2006; 42(15):2623–30.

24. Pompella A, Corti A, Paolicchi A, Giommarelli C, Zunino F. Gamma-glutamyltransferase, redox regulation and cancer drug resistance. Curr Opin Pharmacol. 2007; 7(4):360–6.

25. Coles B, Ketterer B. The role of glutathione and glutathione transferases in chemical carcinogenesis. Crit Rev Biochem Mol Biol. 1990; 25(1):47–70.

26. Xu C, Li CY, Kong AN. Induction of phase I, II and III drug metabolism/transport by xenobiotics. Arch Pharm Res. 2005; 28(3):249–68.